In a special segment broadcast in Panama, Diva D. De León-Crutchlow, MD, MSCE, recalled her path from her home county to her role as Chief of the Division of Endocrinology and Diabetes and Director of the Congenital Hyperinsulinism Center at Children's Hospital of Philadelphia (CHOP).
As COVID-19 continues to spread worldwide, teams at Children’s Hospital of Philadelphia are using a collaborative approach to identify and test potential treatments.
Learn how CHOP’s unique model for predicting COVID-19 spread is helping the country navigate the pandemic.
CHOP’s groundbreaking expertise in treating children with congenital hyperinsulinism (HI) began more than 50 years ago and draws patients from all over the world.
For the seventh consecutive year, the Department of Pediatrics at the University of Pennsylvania’s Perelman School of Medicine, located at Children’s Hospital of Philadelphia, has been ranked number one in the United States.
The IMGC coordinates a genetic testing plan that provides accurate and comprehensive test results within a few weeks.
Physicians who see patients with mitochondrial disease have a practical new tool: the first published care standards to guide clinical care.
In a clinical trial led by Children's Hospital, adult patients with hemophilia B were able to pursue daily activities without disabling bleeds.
Fetal medicine experts at Children's Hospital have performed prenatal heart surgery to remove a life-threatening tumor, called intrapericardial teratoma.